Cytotoxic T lymphocytes directed to the preferentially expressed antigen of melanoma (PRAME) target chronic myeloid leukemia

The cancer testis antigen (CTA) preferentially expressed antigen of melanoma (PRAME) is overexpressed in many hematologic malignancies, including chronic myeloid leukemia (CML). The sensitivity of CML to donor lymphocyte infusion after allogeneic stem cell transplantation suggests this tumor can be...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Quintarelli, Concetta, Dotti, Gianpietro, De Angelis, Biagio, Hoyos, Valentina, Mims, Martha, Luciano, Luigia, Heslop, Helen E., Rooney, Cliona M., Pane, Fabrizio, Savoldo, Barbara
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2008
Matèries:
Neoplasia
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3401035/
https://ncbi.nlm.nih.gov/pubmed/18591381
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-04-150045
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars